Lori Kunkel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Enliven Therapeutics Appoints Dr Lori Kunkel to Board of Directors

BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precisio.

United statesUniversity of southern californiaSan diegoSam kintzLori kunkelEli lillyLos angelesDivision of hematology oncologyEnliven therapeutics incBoard of directors nurix therapeutics incTherapeutics incUniversity of californiaOnyx pharmaceuticalsPharmaceuticals incCompany nasdaqProteolix inc

Enliven Therapeutics Appoints Dr Lori Kunkel to Board of Directors

Enliven Therapeutics Appoints Dr Lori Kunkel to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University of southern californiaUnited statesSan diegoSam kintzLos angelesEli lillyLori kunkelEnliven therapeutics incCompany nasdaqUniversity of californiaBoard of directors nurix therapeutics incDivision of hematology oncologyPharmaceuticals incOnyx pharmaceuticalsTherapeutics incProteolix inc

Longtime BioMarin CEO hands off baton—Chutes & Ladders

Longtime BioMarin CEO hands off baton—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Ocuphire pharmaAmit mehtaDerrell porterKirsty sempleErin lavelleCellevolve bioSarah coleTodd dickinsonAdrian rayPaul frohnaMichelle shuffettJennifer towneMarguerite hutchinsonChristian howellLori kunkelDaiichi sankyo plexxikon

ProfoundBio Readies for Next Phase of Growth with Management Team Additions and Advisory Board Appointment

SEATTLE, November 02, 2023 ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for cancer, today announced the addition of multiple industry veterans to its leadership team to support its growth.

San diegoUnited statesKeck graduate instituteUniversity of southern californiaBaiteng zhaoKevin hamblyXiao shangLori kunkelErin lavelleLos angelesYale universityUniversity of californiaVp corporate development strategy at eliem therapeuticsDivision of hematology oncologySociety for immunotherapy of cancerMerrill lynch co

K36 Therapeutics Announces FDA Clearance of Investigational New Drug Application and Formation of Clinical Advisory Board for Lead Program KTX-1001

/PRNewswire/ K36 Therapeutics, Inc. ("K36"), a privately held biotechnology company developing novel targeted therapies for the unmet medical needs of.

University of san franciscoUnited statesCastillay leópUnited kingdomSan franciscoLori kunkelShaji kumarSuzanne trudelNoopur rajeDavid siegelThomas martinJesus berdejaMichelle kimTerry connollyMyeloma programApplication for the company